|
VPS54 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.783300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.178500E-03 |
| Normal-vs-Stage2 |
2.980000E-01 |
| Normal-vs-Stage3 |
2.505700E-02 |
| Normal-vs-Stage4 |
1.208370E-01 |
| Stage1-vs-Stage2 |
7.171800E-01 |
| Stage1-vs-Stage3 |
6.612600E-01 |
| Stage1-vs-Stage4 |
6.288200E-01 |
| Stage2-vs-Stage3 |
5.111800E-01 |
| Stage2-vs-Stage4 |
5.157200E-01 |
| Stage3-vs-Stage4 |
8.371200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.818600E-04 |
| Normal-vs-AfricanAmerican |
2.287200E-01 |
| Normal-vs-Asian |
4.040400E-01 |
| Caucasian-vs-AfricanAmerican |
1.761570E-01 |
| Caucasian-vs-Asian |
1.381440E-01 |
| AfricanAmerican-vs-Asian |
3.675600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.21120000000386E-05 |
| Normal-vs-Female |
7.580200E-01 |
| Male-vs-Female |
7.813500E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.482100E-02 |
| Normal-vs-Extreme_Weight |
3.615400E-04 |
| Normal-vs-Obese |
3.118000E-02 |
| Normal-vs-Extreme_Obese |
1.495560E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.797000E-01 |
| Normal_Weight-vs-Obese |
8.094600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.002400E-01 |
| Extreme_Weight-vs-Obese |
1.797420E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.123800E-01 |
| Obese-vs-Extreme_Obese |
6.427400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.755400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.018990E-01 |
| Normal-vs-Age(61-80Yrs) |
1.844410E-04 |
| Normal-vs-Age(81-100Yrs) |
6.773900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.489800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.313700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.826000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.064500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.258800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.393600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.320700E-03 |
| Normal-VS-Type2 PRCC |
8.555400E-03 |
| Normal-VS-KIRP CIMP |
7.111600E-01 |
| Normal-VS-Unclassified PRCC |
3.085400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.208200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.058400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.230600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.272400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.448400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.104400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.394390E-04 |
| Normal-vs-N1 |
4.836400E-01 |
| Normal-vs-N2 |
2.374700E-04 |
| N0-vs-N1 |
2.570200E-02 |
| N0-vs-N2 |
1.606050E-01 |
| N1-vs-N2 |
4.773900E-02 |
|
|
